Bioray Biotech Co Ltd Ordinary Shares 7561
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.54
- Dividend Yield (Trailing)
- 0.90%
- Dividend Yield (Forward)
- 0.90%
- Total Yield
- 0.90%
Company Profile
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 91
- Website
- http://www.bio-ray.com.tw
Valuation
|
Metric
|
7561
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.55 |
Price/Sales | 3.54 |
Price/Cash Flow | 48.00 |
Price/Earnings
7561
Financial Strength
|
Metric
|
7561
|
|---|---|
Quick Ratio | 3.52 |
Current Ratio | 5.00 |
Interest Coverage | −10.23 |
Quick Ratio
7561
Profitability
|
Metric
|
7561
|
|---|---|
Return on Assets (Normalized) | −1.88% |
Return on Equity (Normalized) | −2.42% |
Return on Invested Capital (Normalized) | −1.92% |
Return on Assets
7561
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fsccdwjvj | Cycn | $75.7 Bil | |
MKKGY
| Merck KGaA ADR | Wrtcjhrs | Yxkvh | $71.1 Bil | |
HLN
| Haleon PLC ADR | Zmhvnhvd | Pypq | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Bcbrkcgr | Fksnf | $15.9 Bil | |
VTRS
| Viatris Inc | Lvzyxfbvt | Crdvy | $14.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kmjbyzs | Srgl | $12.6 Bil | |
CTLT
| Catalent Inc | Wnknhfmd | Lzqhgz | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Kjplbgjvn | Lkrf | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Cjyfpfkgr | Msr | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xczbyfdn | Sbqzwb | $3.5 Bil |